{"id":"https://openalex.org/W2560893402","doi":"https://doi.org/10.3805/eands.8.21","title":"Appropriate conversion from valproate monotherapy to lamotrigine monotherapy in Japanese women with epilepsy","display_name":"Appropriate conversion from valproate monotherapy to lamotrigine monotherapy in Japanese women with epilepsy","alternate_titles":[],"publication_year":2016,"publication_date":"2016-01-01","ids":{"openalex":"https://openalex.org/W2560893402","doi":"https://doi.org/10.3805/eands.8.21","mag":"2560893402"},"language":"en","primary_location":{"id":"doi:10.3805/eands.8.21","doi":"https://doi.org/10.3805/eands.8.21","is_oa":true,"landing_page_url":"https://doi.org/10.3805/eands.8.21","pdf_url":"https://www.jstage.jst.go.jp/article/eands/8/1/8_21/_pdf","source":{"id":"https://openalex.org/S108509855","display_name":"Epilepsy & Seizure","issn_l":"1882-5567","issn":["1882-5567"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsy &amp; Seizure","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2560893402"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/eands/8/1/8_21/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011629689","display_name":"Takamichi Yamamoto","orcid":"https://orcid.org/0000-0003-4883-1551","observed_orcids":["https://orcid.org/0000-0003-4883-1551"]},"institutions":[{"id":"https://openalex.org/I4210130594","display_name":"Seirei Hamamatsu General Hospital","ror":"https://ror.org/036pfyf12","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210130594"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takamichi Yamamoto","raw_affiliation_strings":["Seirei Hamamatsu General Hospital","Seirei Hamamatsu General Hospital, Shizuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seirei Hamamatsu General Hospital","institution_ids":["https://openalex.org/I4210130594"]},{"raw_affiliation_string":"Seirei Hamamatsu General Hospital, Shizuoka, Japan","institution_ids":["https://openalex.org/I4210130594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086697425","display_name":"Yuichi Kubota","orcid":"https://orcid.org/0000-0002-6487-2065","observed_orcids":["https://orcid.org/0000-0002-6487-2065"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuichi Kubota","raw_affiliation_strings":["Department of Neurosurgery, Asakadai Central General Hospital","Department of Neurosurgery, Asakadai Central General Hospital, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurosurgery, Asakadai Central General Hospital","institution_ids":[]},{"raw_affiliation_string":"Department of Neurosurgery, Asakadai Central General Hospital, Saitama, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071916990","display_name":"Hirohiko Murayama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4210115149","display_name":"GlaxoSmithKline (Japan)","ror":"https://ror.org/01j6sxy67","country_code":"JP","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210115149"]}],"countries":["GB","JP"],"is_corresponding":false,"raw_author_name":"Hirohiko Murayama","raw_affiliation_strings":["Development and Medical Affairs, GlaxoSmithKline K.K","Development and Medical Affairs, GlaxoSmithKline K.K., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Development and Medical Affairs, GlaxoSmithKline K.K","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"Development and Medical Affairs, GlaxoSmithKline K.K., Tokyo, Japan","institution_ids":["https://openalex.org/I4210115149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001590540","display_name":"Hirofumi Ozeki","orcid":"https://orcid.org/0000-0003-4737-8708","observed_orcids":["https://orcid.org/0000-0003-4737-8708"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4210115149","display_name":"GlaxoSmithKline (Japan)","ror":"https://ror.org/01j6sxy67","country_code":"JP","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210115149"]}],"countries":["GB","JP"],"is_corresponding":false,"raw_author_name":"Hirofumi Ozeki","raw_affiliation_strings":["Development and Medical Affairs, GlaxoSmithKline K.K","Development and Medical Affairs, GlaxoSmithKline K.K., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Development and Medical Affairs, GlaxoSmithKline K.K","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"Development and Medical Affairs, GlaxoSmithKline K.K., Tokyo, Japan","institution_ids":["https://openalex.org/I4210115149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035170485","display_name":"Yotaro Numachi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4210115149","display_name":"GlaxoSmithKline (Japan)","ror":"https://ror.org/01j6sxy67","country_code":"JP","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210115149"]}],"countries":["GB","JP"],"is_corresponding":true,"raw_author_name":"Yotaro Numachi","raw_affiliation_strings":["Development and Medical Affairs, GlaxoSmithKline K.K","Development and Medical Affairs, GlaxoSmithKline K.K., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Development and Medical Affairs, GlaxoSmithKline K.K","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"Development and Medical Affairs, GlaxoSmithKline K.K., Tokyo, Japan","institution_ids":["https://openalex.org/I4210115149"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069265637","display_name":"Akio Ikeda","orcid":"https://orcid.org/0000-0002-0790-2598","observed_orcids":["https://orcid.org/0000-0002-0790-2598"]},"institutions":[{"id":"https://openalex.org/I22299242","display_name":"Kyoto University","ror":"https://ror.org/02kpeqv85","country_code":"JP","type":"education","lineage":["https://openalex.org/I22299242"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akio Ikeda","raw_affiliation_strings":["Department of Epilepsy, Movement Disorders and Physiology, Graduate School of Medicine, Kyoto University","Department of Epilepsy, Movement Disorders and Physiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epilepsy, Movement Disorders and Physiology, Graduate School of Medicine, Kyoto University","institution_ids":["https://openalex.org/I22299242"]},{"raw_affiliation_string":"Department of Epilepsy, Movement Disorders and Physiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan","institution_ids":["https://openalex.org/I22299242"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5035170485"],"corresponding_institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4210115149"],"apc_list":null,"apc_paid":null,"fwci":0.2037,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.51004281,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"8","issue":"1","first_page":"21","last_page":"31"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.8359000086784363,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.8359000086784363,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.15860000252723694,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/valproic-acid","display_name":"valproic acid","score":0.8190000057220459},{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":1.0},{"id":"https://openalex.org/keywords/women-of-reproductive-age","display_name":"women of reproductive age","score":0.8090000152587891},{"id":"https://openalex.org/keywords/seizure-control","display_name":"seizure control","score":0.4909999966621399},{"id":"https://openalex.org/keywords/drug-induced-rash","display_name":"drug rash","score":0.5630000233650208},{"id":"https://openalex.org/keywords/hypersensitivity","display_name":"hypersensitivity","score":0.4560000002384186},{"id":"https://openalex.org/keywords/japanese-women","display_name":"Japanese women","score":0.5059999823570251},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.4189999997615814}],"concepts":[{"id":"https://openalex.org/C2778802184","wikidata":"https://www.wikidata.org/wiki/Q410346","display_name":"Lamotrigine","level":3,"score":0.9666354060173035},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.7107298374176025},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6725701093673706},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.38411813974380493},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.36557281017303467},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3494676947593689}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3805/eands.8.21","doi":"https://doi.org/10.3805/eands.8.21","is_oa":true,"landing_page_url":"https://doi.org/10.3805/eands.8.21","pdf_url":"https://www.jstage.jst.go.jp/article/eands/8/1/8_21/_pdf","source":{"id":"https://openalex.org/S108509855","display_name":"Epilepsy & Seizure","issn_l":"1882-5567","issn":["1882-5567"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsy &amp; Seizure","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3805/eands.8.21","doi":"https://doi.org/10.3805/eands.8.21","is_oa":true,"landing_page_url":"https://doi.org/10.3805/eands.8.21","pdf_url":"https://www.jstage.jst.go.jp/article/eands/8/1/8_21/_pdf","source":{"id":"https://openalex.org/S108509855","display_name":"Epilepsy & Seizure","issn_l":"1882-5567","issn":["1882-5567"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsy &amp; Seizure","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G2245966152","display_name":null,"funder_award_id":"15H05871","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G5285102892","display_name":null,"funder_award_id":"15H05874","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320315887","display_name":"GlaxoSmithKline Japan","ror":"https://ror.org/01j6sxy67"},{"id":"https://openalex.org/F4320324177","display_name":"Otsuka Pharmaceutical","ror":"https://ror.org/013k5y296"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2560893402.pdf","grobid_xml":"https://content.openalex.org/works/W2560893402.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W1910200371","https://openalex.org/W1963992854","https://openalex.org/W1982337862","https://openalex.org/W1983142641","https://openalex.org/W1984013967","https://openalex.org/W1989801730","https://openalex.org/W2001070928","https://openalex.org/W2005297857","https://openalex.org/W2043818223","https://openalex.org/W2055922915","https://openalex.org/W2056838552","https://openalex.org/W2072799764","https://openalex.org/W2077018599","https://openalex.org/W2100288005","https://openalex.org/W2103512719","https://openalex.org/W2108052860"],"related_works":["https://openalex.org/W2077018599","https://openalex.org/W2125614487","https://openalex.org/W1992843448","https://openalex.org/W4255794268","https://openalex.org/W3016970870","https://openalex.org/W3016397654","https://openalex.org/W1993982776","https://openalex.org/W2144888247","https://openalex.org/W2066152119","https://openalex.org/W2363858004"],"abstract_inverted_index":{"on":[0,215],"behalf":[1],"of":[2,25,51,150,155,210,243,250,255],"the":[3,22,69,93,106,121,130,148,176,192,207,239,253],"Lamictal":[4],"200776":[5],"Study":[6],"GroupPurpose:":[7],"Exposur":[8],"e":[9,178],"to":[10,38,44,86,102,117,138,147,199,238,266],"sodium":[11],"valpr":[12],"oate":[13],"(VPA)":[14],"dur":[15],"ing":[16],"pr":[17,179],"egnancy":[18],"may":[19],"incr":[20],"ease":[21],"r":[23,183,241,245],"isk":[24],"fetal":[26],"malformations":[27],"and":[28,74,157,227],"cognitive":[29],"developmental":[30],"deficits.We":[31],"therefore":[32],"assessed":[33],"a":[34],"clinically":[35],"practical":[36],"method":[37],"change":[39,75],"treatment":[40],"from":[41,79,191],"VPA":[42,72,82,108,113,127,156,182,231,261],"monotherapy":[43,47,83,88,225,262],"lamotrigine":[45],"(LTG)":[46],"in":[48,71,76,89,185,206,220],"Japanese":[49,258],"women":[50,259],"childbearing":[52],"potential":[53],"whose":[54],"seizures":[55,152],"were":[56,189,217],"controlled":[57],"by":[58,92,136],"VPA.":[59],"Methods:In":[60],"an":[61],"open-label,":[62],"single":[63],"arm,":[64],"multicenter":[65],"study,":[66],"we":[67],"evaluated":[68],"reduction":[70],"dose":[73,98,109,114,123,132,143],"seizure":[77,167],"frequency":[78],"baseline":[80],"when":[81],"was":[84,99,110,115,124,128,133,144,164],"switched":[85],"LTG":[87,97,122,131,142,158,160,195,211,224,256,267],"female":[90],"patients":[91,171,188,222],"following":[94],"protocol.(1)":[95],"The":[96,112,141],"increased":[100,135],"up":[101,137],"200":[103],"mg/day":[104,119],"while":[105,120],"initial":[107],"maintained.(2)":[111],"reduced":[116],"0":[118],"maintained.(3)":[125],"When":[126],"removed,":[129],"simultaneously":[134],"100":[139],"mg/day.(4)":[140],"further":[145],"adjusted.Due":[146],"risk":[149],"break-through":[151],"during":[153,194,223],"adjustment":[154],"doses,":[159],"trough":[161],"serum":[162],"concentration":[163],"measured":[165],"for":[166],"control.Results:":[168],"Of":[169],"33":[170],"enr":[172],"olled,":[173],"20":[174],"completed":[175],"entir":[177],"otocol,":[180],"with":[181],"emoval":[184],"19":[186],"patients.Thirteen":[187],"withdrawn":[190],"study":[193],"escalation,":[196,257],"mainly":[197],"due":[198],"LTG-related":[200],"skin":[201,244],"rash":[202],"(n":[203],"=":[204],"8)":[205],"early":[208],"stage":[209],"initiation":[212],"(10":[213],"days":[214],"average).Seizures":[216],"observed":[218],"once":[219],"2":[221],"(7":[226],"13":[228],"weeks":[229],"after":[230],"removal).Discussions:":[232],"By":[233],"paying":[234],"car":[235],"eful":[236],"attention":[237],"occur":[240],"ence":[242],"ash":[246],"or":[247],"any":[248],"sign":[249],"hypersensitivity":[251],"at":[252],"beginning":[254],"receiving":[260],"can":[263],"be":[264],"converted":[265],"monotherapy.":[268]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2560893402","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-01-06T00:00:00"}
